Invesaro

Stocks NI Financial statements

Financial statements

NISOURCE INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data NISOURCE INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue4,4934,8754,9915,0534,4734,7315,7395,3485,2836,523
Cost of revenue1,3901,5191,7611,5351,1091,3922,1111,5331,1321,584
Gross profit4,4934,8755,1155,2093,3643,3393,6283,8154,1514,938
Operating expenses3,6263,9534,9904,318
Operating income8669211258915511,0071,2661,2961,4561,835
Interest expense350353353379371341362490517639
Other non-operating income-353-478-355-384-582-300-309-482-453-619
Pre-tax income514443-231507-31.37079568141,0031,216
Income tax182315-180124-17.1118165140158204
Income from continuing operations328129
Net income to minority interests003.43.9-12.3-39.984.383.1
Net income332129-50.6383-17.6585804714760930
EBITDA1,4131,4927241,6081,2771,7552,0872,2042,4993,003
EPS, basic1.030.39-0.180.88-0.191.351.841.591.631.96
EPS, diluted1.020.39-0.180.87-0.191.271.701.481.621.95
Shares, basic (weighted)322329356375384394407416454473
Shares, diluted (weighted)324331356376384417443448456475
Dividend per share0.640.700.780.800.840.880.941.001.061.12

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents26.42911313911784.240.82,245157110
Receivables8478991,0598577918261,0428629641,198
Other current assets13113313070.28619621013.124.289.3
Total current assets1,7621,7632,0551,8541,6591,9212,5844,4992,0802,377
Property, plant and equipment13,06814,36015,54316,91216,62017,88219,84322,27525,45428,688
Lease right-of-use assets64.239.933.835.732.926.425.8
Goodwill1,6911,6911,6911,4861,4861,4861,4861,4861,4861,486
Intangible assets243232221000
Long-term investments15417117215215986.7146
Other non-current assets3,6623,6294,0003,6643,5104,0954,0864,0564,0754,521
Total assets18,69219,96221,80422,66022,04124,15726,73731,07731,78835,859
Accounts payable5396268846665896989007498631,125
Accrued liabilities161195150156142183168228268247
Deferred revenue256243238325294269283
Short-term debt3632845013.423.358.13023.81,28119.7
Total current liabilities3,4523,1784,0373,7462,2792,7464,6615,2654,1133,457
Long-term debt6,0587,5127,1057,8569,2209,1839,52411,05612,07515,458
Lease liabilities51.629.927.931.925.818.217.2
Other non-current liabilities201194178228516690297299313258
Total liabilities14,62115,64216,05316,67316,20316,88418,83520,94121,12024,199
Total debt6,4217,7977,1557,8709,2439,2429,55423.81,28119.7
Paid-in capital5,1545,5296,4046,6666,8907,2047,3758,8809,5229,867
Retained earnings-972-1,073-1,399-1,371-1,765-1,581-1,214-967-712-315
Treasury stock-88.7-95.9-99.9-99.9-99.9-99.9-99.9-99.9-99.9-99.9
Other comprehensive income-25.1-43.4-37.2-92.6-157-127-37.1-33.6-30.4-6.2
Shareholders' equity4,0714,3205,7515,9875,7526,9477,5758,2708,6849,450
Minority interests085.63263261,8671,9842,210
Total equity4,0714,3205,7515,9875,8387,2737,90210,13610,66811,660
Total liabilities and equity18,69219,96221,80422,66022,04124,15726,73731,07731,78835,859
Shares outstanding323337372382392405412447470478

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income332129-50.6383-14.25897926748451,013
Depreciation and amortization5475706007177267488219081,0431,168
Stock-based compensation46.540.128.625.917.424.324.933.543.650.9
Deferred income tax184308-187120-27.8113158135169237
Change in receivables-188-52.3-186188-3.9-40.3-216184-102-273
Change in inventory38.91941.4-2-1.5-113-259234102-60.3
Change in payables10949268-300-29.754.9165-17271.5132
Cash from operations8037425401,5831,1041,2181,4091,9351,7822,362
Capital expenditures-1,475-1,696-1,818-1,802-1,758-1,838-2,203-2,646-2,614-2,782
Purchases of investments-38.3-168-90-140-145-103-73.5-42.8-17.8-93.9
Sales and maturities of investments3316382.313213197.875.739.993.239.3
Cash from investing-1,603-1,809-1,926-1,922-879-2,205-2,570-3,572-3,213-4,524
Debt issued5003,2503507502,97403461,4892,2303,352
Debt repaid00-1,260
Stock issued23.133784824421130015412.9613312
Share buybacks-9.4-7.2-400
Dividends paid-206-229-273-299-322-345-382-414-481-530
Cash from financing7911,0691,469366-2489561,1413,842-6512,099
Net change in cash2.482.727.3-22.8-30.7-19.52,206-2,083-62.9
Free cash flow-672-954-1,278-219-654-620-794-711-833-420
Interest paid338340354350349322344434468557
Income taxes paid85.53.310.8-15.47.29.44.33.3

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $39.42 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin86.5%Gross profit / revenue.
Operating margin16.4%Operating income / revenue.
EBITDA margin27.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin10.1%Pre-tax income / revenue.
Net margin8.0%Net income / revenue.
FCF margin-9.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin20.2%Cash from operations / revenue.
Effective tax rate14.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)9.5%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)2.4%Net income / average total assets.
Return on invested capital (ROIC)6.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue29.8%Capital expenditures / revenue.
D&A / revenue11.2%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y23.5%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y4.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y7.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y19.0%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y10.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y8.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y26.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y13.2%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y27.2%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y20.2%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y12.9%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y18.7%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y22.2%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y4.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y20.4%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y4.7%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y32.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y18.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y16.4%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y5.7%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y6.0%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y5.9%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y8.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y7.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y10.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y12.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y10.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y10.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y4.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y2.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y4.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.50xCurrent assets / current liabilities.
Quick ratio0.21x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.02x(Cash + short-term investments) / current liabilities.
Debt / equity1.75xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets44.5%Total debt / total assets.
Liabilities / assets68.3%Total liabilities / total assets.
Net debt$16.64BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA5.31xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage2.45xOperating income / interest expense.
Working capital-$2.22BCurrent assets - current liabilities.
Goodwill and intangibles / assets4.0%(Goodwill + intangible assets) / total assets.
Tangible book value$8.09BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.30xRevenue / average total assets.
Receivables turnover13.4xRevenue / average receivables.
Days sales outstanding27 days365 x average receivables / revenue.
Days payables270 days365 x average accounts payable / cost of revenue.
FCF conversion-120.0%Free cash flow / net income, when net income is positive.
Capex / operating cash flow147.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.88Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$23.64Revenue / diluted weighted shares.
FCF per share-$2.26Free cash flow / diluted weighted shares.
Operating cash flow per share$4.79Cash from operations / diluted weighted shares.
Book value per share$19.97Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$16.87Tangible book value / shares outstanding.
Cash per share$0.15(Cash + short-term investments) / shares outstanding.
Payout ratio61.8%Dividends paid / net income, when net income is positive.

Valuation

MetricValueHow it is calculated
Market cap$18.90BShare price x shares outstanding.
Enterprise value$35.55BMarket cap + total debt - cash - short-term investments.
P/E20.9xMarket cap / net income. Only when net income is positive.
P/S1.66xMarket cap / revenue.
P/B1.97xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book2.34xMarket cap / tangible book value, when positive.
P/OCF8.21xMarket cap / cash from operations, when positive.
EV/Sales3.12xEnterprise value / revenue.
EV/EBIT19.1xEnterprise value / operating income, when both are positive.
EV/EBITDA11.3xEnterprise value / EBITDA, when both are positive.
FCF yield-5.7%Free cash flow / market cap.
Earnings yield4.8%Net income / market cap (the inverse of P/E).
Dividend yield3.0%Dividends paid over the period / market cap.
Shareholder yield3.0%(Dividends paid + share buybacks) / market cap.
PEG4.46xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was NISOURCE INC.'s revenue in fiscal 2025?

NISOURCE INC. reported revenue of $6.52B for fiscal 2025, 23.5% higher than the year before.

Was NISOURCE INC. profitable in fiscal 2025?

Yes. Net income was $929.5M, a net margin of 14.3%.

How much free cash flow did NISOURCE INC. generate in fiscal 2025?

Cash from operations of $2.36B minus capital expenditures of $2.78B left free cash flow of -$420.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to NISOURCE INC.